Loading... 2 0 20 0 false
Credit Name
Cecily Forsyth
Full Name
Forsyth, Cecily
Forsyth, Cecily J
Main Affilation
Central Coast Local Health District
Loading... 3 0 20 0 false


Results 1-53 of 53 (Search time: 0.002 seconds).

PreviewIssue DateTitleAuthor(s)
11-Mar-2024Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuriaKulasekararaj, Austin GLehtinen, Anna-ElinaForsyth, Cecily Gandhi, ShreyansGriffin, MoragKörper, SixtenMikala, GaborMuus, PetraOvergaard, UlrikPatriquin, Christopher JPullon, HumphreyShen, Yu-MinSpearing, RuthSzer, JeffDe la Borderie, GuillemetteDuda, Petra WFarzaneh-Far, RaminRagunathan, SharanSayegh, Camil EVadysirisack, Douangsone DSchrezenmeier, Hubert
222-Nov-2023Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryNg, Wei YangErber, Wendy NGrigg, AndrewDunne, KarinPerkins, AndrewForsyth, Cecily Ross, David M
35-Jul-2023Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variantsHoman, Claire CDrazer, Michael WYu, KaiLawrence, David MichaelFeng, JinghuaArriola-Martinez, Luis AlbertoPozsgai, Matthew JMcNeely, Kelsey EHa, Thuong ThiVenugopal, ParvathyArts, PeerKing-Smith, SarahCheah, Jesse JcArmstrong, MarkWang, PaulBödör, CsabaCantor, Alan BCazzola, MarioDegelman, Erin SDiNardo, Courtney DDuployez, NicolasFavier, RémiFröhling, StefanRio-Machin, AnaKlco, Jeffery MKrämer, AlwinKurokawa, MineoLee, JoanneMalcovati, LucaMorgan, Neil VGeorges, NatsoulisOwen, CarolynPatel, Keyur PPreudhomme, ClaudeRaslova, HanaRienhoff, Hugh YoungRipperger, TimSchulte, Rachael RTawana, KiranVelloso, ElviraBenedict, YanKim, Erika Mijin KwonSood, RamanHsu, Amy PHolland, Steven MPhillips, KerryPoplawski, NicolaBabic, MilenaWei, Andrew HForsyth, Cecily J Mar Fan, HelenLewis, IanCooney, Julian PSusman, RachelFox, Lucy CBlombery, PiersSinghal, DeepakHiwase, Devendra KPhipson, BelindaSchreiber, Andreas WHahn, Christopher NScott, Hamish SLiu, Paul PGodley, Lucy ABrown, Anna L
420-Dec-2022Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registryNguyen, JamesWellard, CameronChung, ElizaCheah, Chan YDickinson, MichaelDoo, Nicole WongKeane, ColmTalaulikar, DiptiBerkahn, LeanneMorgan, SusanHamad, NadaCochrane, TaraJohnston, Anna MForsyth, Cecily J Opat, StephenBarraclough, AllisonMutsando, HowardRatnasingam, SumitaGiri, PratyushWood, Erica MMcQuilten, Zoe KHawkes, Eliza A
514-Jun-2022Paraprotein associated heparin resistance during cardiopulmonary bypassKhuong, Jacqueline NForsyth, Cecily J Manuel, LucyKingsford-Smith, KateSrivastava, ArpitBassin, Levi
6Jul-2021Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case reportRogers, James Forsyth, Cecily J Ford, Tom Mikhail, Philopatir 
7Oct-2020Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductForsyth, Cecily J Niederwieser, D.Hamm, C.Cobb, P.Mo, M.Tucci, A.Hanes, V.Delwail, V.Hajek, R.Chien, D.
8Apr-2020Cutaneous multiple myelomaForsyth, Cecily J Jagger, Jacqueline Lai, S.
9Feb-2020Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing lossForsyth, Cecily J Venugopal, P.Gagliardi, L.Feng, J.Phillips, K.Babic, M.Poplawski, N.K.Rienhoff, H.Y.,Jr.Schreiber, A.W.Hahn, C.N.Brown, A.L.Scott, H.S.
10Sep-2019Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationForsyth, Cecily J Joshi, M.Taper, J.Rowlings, P.Campbell, P.Crispin, P.Harvey, M.Underhill, C.Bayley, A.Byth, K.Huang, G.Hertzberg, M.
11Apr-2019Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014Forsyth, Cecily J Baade, P.D.Ross, D.M.Anderson, L.A.Fritschi, L.
12Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaForsyth, Cecily J Minson, A.G.Cummins, K.Fox, L.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
13Jan-2019Hereditary haemorrhagic telangiectasiaForsyth, Cecily J Mangkorntongsakul, Varitsara 
14Dec-2018The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complicationsForsyth, Cecily J Melville, K.Tiley, Campbell 
15Nov-2018Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasmsForsyth, Cecily J Chan, Wai-Hoong Grigg, A.Cook, N.C.Lane, S.W.Burbury, K.Perkins, A.C.Ross, D.M.
16Aug-2018Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesForsyth, Cecily J Godfrey, A.L.Campbell, P.J.MacLean, C.Buck, G.Cook, J.Temple, J.Wilkins, B.S.Wheatley, K.Nangalia, J.Grinfeld, J.McMullin, M.F.Kiladjian, J.J.Green, A.R.Harrison, C.N.
17Apr-2018Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaForsyth, Cecily J Crassini, K.R.Zhang, E.Balendran, S.Freeman, J.A.Best, O.G.Mackinlay, N.J.Han, P.Stevenson, W.S.Mulligan, S.P.
18Jan-2018Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thrombosesForsyth, Cecily J HarrisonBalendran, S.Harrison, A.Morel-Kopp, M. C.Ward, C.
19May-2017Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyForsyth, Cecily J Quach, H.Fernyhough, L.Henderson, R.Corbett, G.Baker, B.Browett, P.Blacklock, H.Underhill, C.Cannell, P.Trotman, J.Neylon, A.Harrison, S.Link, E.Swern, A.Cowan, L.Dimopoulos, M.A.Miles Prince, H.
20May-2017Raccoon eyes in systemic light chain amyloidosisForsyth, Cecily J Tiley, Campbell 
21May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaForsyth, Cecily J Fox, L.Cummins, K.D.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
22Mar-2017A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisForsyth, Cecily J Ho, P.J.Bajel, A.Burbury, K.Dunlop, L.Durrant, S.Perkins, A.C.Ross, D.M.
23Feb-2017Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.Forsyth, Cecily J Agarwal, R.Blombery, P.McBean, M.Jones, K.Fellowes, A.Doig, K.Westerman, D.A.
24Jan-2017Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaForsyth, Cecily J Douglas, G.Harrison, C.N.Bennett, M.Stevenson, W.S.Hounsell, J.Ratnasingam, S.Ritchie, D.Ross, D.M.Grigg, A.
25Aug-2016Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortForsyth, Cecily J Campbell, P.J.MacLean, C.Beer, P.A.Buck, G.Wheatley, K.Kiladjian, J.J.Harrison, C.N.Green, A.R.
26Apr-2016Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasmsForsyth, Cecily J Malherbe, J.A.Fuller, K.A.Mirzai, B.Kavanagh, S.So, C.C.Ip, H.W.Guo, B.B.Howman, R.Erber, W.N.
27Oct-2015The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathwayForsyth, Cecily J Best, O.G.Singh, N.Mulligan, S.P.
28Feb-2015The oral iron chelator deferasirox inhibits NF-kappaB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaForsyth, Cecily J Banerjee, A.Mifsud, N. A.Bird, R.Szer, J.Tam, C.Kellner, S.Grigg, A.Motum, P.Bentley, M.Opat, S.Grigoriadis, G.
29Feb-2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.Yeung, D.Osborn, M.White, D.Branford, S.Braley, J.Herschtal, A.Kornhauser, M.Issa, S.Hiwase, D.Hertzberg, M.Schwarer, A.Filshie, R.Arthur, C.Kwan, Y.L.Trotman, J.Forsyth, Cecily J Taper, J.Ross, D.M.Beresford, J.Tam, C.Mills, A.K.Grigg, A.Hughes, T.
30Jul-2014Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapyForsyth, Cecily J Paidas, M.J.Quere, I.Rodger, M.
31May-2014Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyureaForsyth, Cecily J Verner, E.Grigg, A.
32Aug-2013A multicenter, open-label, noncomparative screening study of Enzastaurin in adult patients with Non-Hodgkin LymphomasForsyth, Cecily J Gomez-Almaguer, D.Camargo, J.F.C.Eliadis, P.E.Crespo-Solis, E.Pereira, J.Gutierrez-Aguirre, C.H.Rivaz-Vera, S.Roberson, S.Lin, B.Smith, N.V.Hamid, O.
33Jan-2013Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaForsyth, Cecily J Freeman, J.A.Crassini, K.R.Best, O.G.Mackinlay, N.J.Han, P.Stevenson, W.S.Mulligan, S.P.
34Jul-2012The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseForsyth, Cecily J Best, O.G.Che, YSingh, N.Christopherson, R.I.Mulligan, S.P.
35Apr-2012When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?Forsyth, Cecily J Bird, R.Kenealy, M.Wellwood, J.Leahy, M.F.Seymour, J.F.To, L.B.
36Feb-2012Distinguishing types 1 and 2M von Willebrand diseaseForsyth, Cecily J Favaloro, E.J.Koutts, J.
37Aug-2011Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participantsForsyth, Cecily J Trotman, J.Fournier, MLamy, T.Seymour, J.F.Sonet, A.Janikova, A.Shpilberg, O.Gyan, E.Tilly, H.Estell, J.Decaudin, D.Fabiani, B.Gabarre, J.Salles, B.Van Den Neste, E.Canioni, D.Garin, E.Fulham, M.Vander Borght, T.Salles, G.
38Dec-2001Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal?Forsyth, Cecily J Favaloro, E.J.Nair, S.C.
39Oct-2001Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19: a novel rearrangement in a patient with myelodysplastic syndrome transforming to acute myeloid leukemiaForsyth, Cecily J Smith, A.Heaps, L.S.Sharma, P.Jarvis, A.
40Feb-1999Hodgkin's disease: a GP's guide to diagnosis and managementForsyth, Cecily J 
41May-1997Management of acute vascular graft thrombosis associated with HIT syndrome: a case reportForsyth, Cecily J Wilson, M.McGahan, T.White, G.
42Sep-1996Rapid quantitation of mixed red cell populations using flow cytometryForsyth, Cecily J Nelson, M.Popp, H.Gibson, J.
43Mar-1996Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect?Forsyth, Cecily J Nelson, M.Popp, H.Snowdon, L.Gibson, J.Joshua, D.
44Feb-1996Thalidomide responsive chronic pulmonary GVHDForsyth, Cecily J Cremer, P.D.Torzillo, P.Iland, H.J.Young, G.A.
451996A quick differentiation between iron deficiency and thalassaemia syndromeForsyth, Cecily J Yuen, S.Brown, R.Zarkos, K.
46Oct-1995Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young menForsyth, Cecily J Adams, M.R.Jessup, W.Robinson, J.Celermajer, D.S.
47Mar-1995Severe hemolysis due to anti-D in a D-negative recipient of an orthotopic liver transplantForsyth, Cecily J Popp, H.Kronenberg, H.McCaughan, G.
48Feb-1995First trimester antigen typing of fetal red cells using a flow cytometric techniqueForsyth, Cecily J Nelson, M.Popp, H.Peat, B.Boogert, A.Gibson, J.
491995Quantifying the loss of ABO antigenicity in a patient with acute myeloid leukemia by flow cytometric analysisForsyth, Cecily J Popp, H.J.Nelson, M.Falson, M.Kronenberg, H.
501995Transfusion of patients with haemoglobinopathiesForsyth, Cecily J Chisholm, J.Popp, H.
51Dec-1994Rapid detection of Rh(D)- or K-positive fetal red cells in chorion villus samples by a flow cytometric techniqueForsyth, Cecily J Nelson, M.Popp, H.Gibson, J.
521994Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative womenForsyth, Cecily J Nelson, M.Popp, H.Horky, K.Gibson, J.
53Nov-1992Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronForsyth, Cecily J Coates, A.S.Childs, A.Cox, K.Joshua, D.E.McNeil, E.Grygiel, J.J.